HIKMA Pharmaceuticals PLC Logo

HIKMA Pharmaceuticals PLC

ISIN

GB00B0LCW083

Ticker

HIK

Sector

Health Care

Sub-Industry

Pharmaceuticals

Country

United Kingdom

Year Founded

1978

About HIKMA Pharmaceuticals PLC

Company Description

Hikma Pharmaceuticals PLC is a global pharmaceutical company that is dedicated to providing high-quality, affordable medications to patients worldwide. With its headquarters in London, UK, and operations in the Middle East, Africa, Europe, and the United States, Hikma has established itself as a leader in the pharmaceutical industry.

The company has a diversified product portfolio that includes branded, generic, and injectable pharmaceuticals. Its focus is on developing and manufacturing innovative solutions for complex diseases, such as oncology, respiratory, and injectables.

Headcount

8,700

Served Area

Worldwide

Headquarters

1 New Burlington Place
W1S 2HR, London
United Kingdom

Short Interest


Current short interest

Position Holder Short Interest in Percent Date
Millennium International Management LP 0.69% 17.10.23
Millennium International Management LP 0.60% 03.11.23
Millennium International Management LP 0.59% 25.10.23
Millennium International Management LP 0.52% 11.09.23
Millennium International Management LP 0.53% 29.09.23
Millennium International Management LP 0.63% 28.02.24
Millennium International Management LP 0.73% 10.10.23
Millennium International Management LP 0.70% 24.01.24
Millennium International Management LP 0.64% 06.03.24
Millennium International Management LP 0.59% 13.11.23
Millennium International Management LP 0.57% 31.01.24
Millennium International Management LP 0.51% 08.01.24
Total 7.30%

Capital Markets Information

ISIN

GB00B0LCW083

LEI

213800HEZ5RG2KU77V41

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

London Stock Exchange

Stock Index

FTSE 250

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.